Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
Mayo Clinic · with Congressionally Directed Medical Research Programs · NCT06541210
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 250
- US sites recruiting
- 1
- Study start
- May 4, 2024
- Record last updated
- September 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This clinical trial the possibility of establishing a Community Living Labs (CoLLab) Learning Health System to facilitate access to prostate health Risk, Education, and Assessment in the Community with Help (REACH) services in Black men and compares the impact to American Legion Posts with no CoLLab set up at the individual and community levels. Cancer is the second leading cause of death for Black men and Black men are less likely to receive prostate cancer screening. CoLLab Learning Health System utilizes community health workers (CHW) that are well-trained to form a bridge between communities and clinicians. In fact, Black men who work with CHW's typically have better access to health services, gain knowledge about cancer, cancer prevention, treatment and may have better overall health outcomes. Establishing a CoLLab Learning Health System at American Legion Posts may improve access to clinical trials and prostate cancer services in Black men.
Being studied: Community Health Service; Questionnaire Administration
Conditions: Prostate Carcinoma
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- AIMS 1 AND 3: Participants must be one of the following key personnel:
- Community PI (n=1),
- CoLLab Program Manager (n=1)
- CoLLab Site Managers (n=3)
- CoLLab CAB members (n=21)
- 2 Community Health Workers (CHWs) per Post site (n=6)
- AIMS 1 AND 3: Between the ages of 21 and 80.
- AIMS 1 AND 3: Able to complete the survey in English.
- AIMS 1 AND 3: Reside in the Jacksonville, FL and/or surrounding counties.
- AIMS 1 AND 3: Willing and able to consent to the study.
- AIM 2: Black adult of any gender.
- AIM 2: Must be between the ages of 30 and 80.
- AIM 2: Able to speak English.
- AIM 2: Reside in the Jacksonville, FL and/or surrounding counties.
- AIM 2: Willing and able to consent to the study.
Exclusion Criteria
- AIMS 1 AND 3: Younger than 21years or older than 80 years.
- AIMS 1 AND 3: Not a resident of NE Florida. Unwilling or unable to consent to the study.
- AIM 2: Younger than 30 years or older than 80 years.
- AIM 2: Not a resident of NE Florida.
- AIM 2: Unwilling or unable to consent to the study.
Recruiting US locations
Mayo Clinic in Florida
Jacksonville, FL 32224-9980
Site contact: Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu
Study contacts (from the official record)
- Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu
- Quincy Wimberly · 904-953-0974 · Wimberly.Quincy@mayo.edu
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65